Organogenesis Holdings (ORGO) Cash from Operations (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Cash from Operations of 21127000.0 for Q1 2026, up 205.98% year-over-year from 6904712.44 in Q1 2025, and down 46.41% quarter-over-quarter from 39420000.0 in Q4 2025.
Organogenesis Holdings (ORGO) Cash from Operations (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Cash from Operations history runs 11 years deep, the most recent figure standing at 21127000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 205.98% year-over-year to 21127000.0; the TTM figure through Mar 2026 stood at 30753000.0 (up 593.42% YoY), while the FY2025 annual figure was 10309000.0, down 172.56% from the prior year.
- Cash from Operations for Q1 2026 stood at 21127000.0, down from 39420000.0 in the prior quarter.
- The five-year high for Cash from Operations was 39420000.0 in Q4 2025, with the low at 32873000.0 in Q2 2025.
- The 5-year median for Cash from Operations is 7800000.0 (2022), against an average of 4753058.82.
- Peak annual rise in Cash from Operations reached 260.43% in 2025, while the deepest fall reached 793.82% in 2025.
- Organogenesis Holdings' Cash from Operations stood at 7800000.0 in 2022, then soared by 36.08% to 10614000.0 in 2023, then advanced by 3.04% to 10937000.0 in 2024, then jumped by 260.43% to 39420000.0 in 2025, then plunged by 46.41% to 21127000.0 in 2026.
- Business Quant data shows ORGO's Cash from Operations at 21127000.0 in Q1 2026, 39420000.0 in Q4 2025, and 3079000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn | -31.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.65 Mn |
| Jun 30, 2026 | -31.65 Mn |
| Mar 31, 2026 | 21.13 Mn |
| Mar 31, 2026 | 21.13 Mn |
| Dec 31, 2025 | 39.42 Mn |
| Dec 31, 2025 | 39.42 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | -32.87 Mn |
| Jun 30, 2025 | -32.87 Mn |
| Mar 31, 2025 | -19.94 Mn |
| Mar 31, 2025 | -19.94 Mn |
| Dec 31, 2024 | 10.94 Mn |
| Dec 31, 2024 | 10.94 Mn |
| Sep 30, 2024 | 8.70 Mn |
| Sep 30, 2024 | 8.70 Mn |
| Jun 30, 2024 | 4.74 Mn |
| Jun 30, 2024 | 4.74 Mn |
| Mar 31, 2024 | -10.16 Mn |
| Mar 31, 2024 | -10.16 Mn |